{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T23:02:47Z","timestamp":1772665367270,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bbadis.2025.168029","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T03:19:01Z","timestamp":1756437541000},"page":"168029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["m6A mRNA methylation initiated by METTL14 promotes STK11 translation and increases STK11 activity to induce anti-HER2 therapy resistance in breast cancer"],"prefix":"10.1016","volume":"1872","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaozhou","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yijia","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jue","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0005","first-page":"14","article-title":"The breast cancer tumor microenvironment and precision medicine: immunogenicity and conditions favoring response to immunotherapy","volume":"4","author":"Nicolini","year":"2024","journal-title":"J Natl Cancer Cent"},{"issue":"3","key":"10.1016\/j.bbadis.2025.168029_bb0010","first-page":"222","article-title":"Understanding the role of endothelial cells in brain tumor formation and metastasis: a proposition to be explored for better therapy","volume":"3","author":"Agnihotri","year":"2023","journal-title":"J Natl Cancer Cent"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0015","first-page":"39","article-title":"The efficacy of tucatinib-based therapeutic approaches for HER2-positive breast cancer","volume":"9","author":"Sirhan","year":"2022","journal-title":"Mil. Med. Res."},{"key":"10.1016\/j.bbadis.2025.168029_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2024.102761","article-title":"The evolving landscape of metastatic HER2-positive, hormone receptor-positive breast cancer","volume":"128","author":"Boscolo Bielo","year":"2024","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168029_bb0025","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bbadis.2025.168029_bb0030","first-page":"139","article-title":"Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL)","volume":"1","author":"Yang","year":"2021","journal-title":"J Natl Cancer Cent"},{"issue":"3","key":"10.1016\/j.bbadis.2025.168029_bb0035","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41571-023-00849-9","article-title":"Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives","volume":"21","author":"Marra","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.bbadis.2025.168029_bb0040","first-page":"22","article-title":"Mechanisms of action and resistance to anti-HER2 antibody-drug conjugates in breast cancer","volume":"7","author":"Saleh","year":"2024","journal-title":"Cancer Drug Resist"},{"issue":"7","key":"10.1016\/j.bbadis.2025.168029_bb0045","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.annonc.2024.04.002","article-title":"Antibody-drug conjugates in lung and breast cancer: current evidence and future directions-a position statement from the ETOP IBCSG partners foundation","volume":"35","author":"Peters","year":"2024","journal-title":"Ann. Oncol."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168029_bb0050","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41571-024-00924-9","article-title":"HER2-targeted therapies beyond breast cancer - an update","volume":"21","author":"Yoon","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168029_bb0055","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/endrev\/bnad020","article-title":"Epigenetic dysregulation in endometriosis: implications for pathophysiology and therapeutics","volume":"44","author":"Marquardt","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2025.168029_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115477","article-title":"N6-methyladenosine (m6A) in cancer therapeutic resistance: potential mechanisms and clinical implications","volume":"167","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bbadis.2025.168029_bb0065","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/s41417-023-00628-9","article-title":"RNA N6-methyladenosine (m6A) modification in HNSCC: molecular mechanism and therapeutic potential","volume":"30","author":"Sun","year":"2023","journal-title":"Cancer Gene Ther."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12943-022-01500-4","article-title":"The role of m6A RNA methylation in cancer metabolism","volume":"21","author":"An","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-022-01231-5","article-title":"Functions, mechanisms, and therapeutic implications of METTL14 in human cancer","volume":"15","author":"Guan","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13045-023-01477-7","article-title":"Methyltransferase-like proteins in cancer biology and potential therapeutic targeting","volume":"16","author":"Qi","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0085","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13045-021-01204-0","article-title":"N6-methyladenosine reader IMP2 stabilizes the ZFAS1\/OLA1 axis and activates the Warburg effect: implication in colorectal cancer","volume":"14","author":"Lu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"2","key":"10.1016\/j.bbadis.2025.168029_bb0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41418-023-01247-5","article-title":"LncRNA LY6E-DT and its encoded metastatic-related protein play oncogenic roles via different pathways and promote breast cancer progression","volume":"31","author":"Liu","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2025.168029_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216746","article-title":"Lnc-PLCB1 is stabilized by METTL14 induced m6A modification and inhibits helicobacter pylori mediated gastric cancer by destabilizing DDX21","volume":"588","author":"Chang","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0100","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12864-021-08221-w","article-title":"The Dawn of next generation DNA sequencing in myelodysplastic syndromes- experience from Pakistan","volume":"22","author":"Anwar","year":"2021","journal-title":"BMC Genomics"},{"issue":"22","key":"10.1016\/j.bbadis.2025.168029_bb0105","doi-asserted-by":"crossref","DOI":"10.1172\/JCI159628","article-title":"RAD21 amplification epigenetically suppresses interferon signaling to promote immune evasion in ovarian cancer","volume":"132","author":"Deng","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bbadis.2025.168029_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13073-022-01029-7","article-title":"A pan-cancer landscape of telomeric content shows that RAD21 and HGF alterations are associated with longer telomeres","volume":"14","author":"Sharaf","year":"2022","journal-title":"Genome Med."},{"issue":"21","key":"10.1016\/j.bbadis.2025.168029_bb0115","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/0008-5472.CAN-22-0800","article-title":"ALKBH5-mediated m6A demethylation of GLUT4 mRNA promotes glycolysis and resistance to HER2-targeted therapy in breast Cancer","volume":"82","author":"Liu","year":"2022","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bbadis.2025.168029_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/cells10113129","article-title":"STK11\/LKB1 modulation of the immune response in lung Cancer: from biology to therapeutic impact","volume":"10","author":"Pons-Tostivint","year":"2021","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.bbadis.2025.168029_bb0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jtho.2021.10.013","article-title":"Diminished efficacy of programmed death-(ligand)1 inhibition in STK11- and KEAP1-mutant lung adenocarcinoma is affected by KRAS mutation status","volume":"17","author":"Ricciuti","year":"2022","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.bbadis.2025.168029_bb0130","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cmet.2022.04.003","article-title":"Glutaminase inhibition impairs CD8 T cell activation in STK11\u2212\/Lkb1-deficient lung cancer","volume":"34","author":"Best","year":"2022","journal-title":"Cell Metab."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925003771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925003771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:55:00Z","timestamp":1761116100000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925003771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0925443925003771"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168029","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"m6A mRNA methylation initiated by METTL14 promotes STK11 translation and increases STK11 activity to induce anti-HER2 therapy resistance in breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.168029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168029"}}